Welcome back Rounds Table Listeners!

We are back today with our Classic Rapid Fire Podcast!

This week, Drs. John Fralick and Justin Boyle discuss two recent papers exploring the role of semaglutide in CKD in patients with Type II Diabetes and the utility of tirzepatide in metabolic dysfunction-associated steatohepatitis with liver fibrosis. Two papers, here we go!

1. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (0:00 – 09:32).
2. Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis (09:32 – 17:06).

And for the Good Stuff:

• Congratulations to everyone starting/progressing through residency/finishing their training! (17:06 – 17:43).
• Calgary officials aiming for 'low end' of repair timeline after pipes arrive from San Diego (17:43 – 19:06).

Questions? Comments? Feedback? We’d love to hear from you! @roundstable